219 related articles for article (PubMed ID: 36585787)
1. Discovery of fusion circular RNAs in leukemia with KMT2A::AFF1 rearrangements by the new software CircFusion.
Dal Molin A; Tretti Parenzan C; Gaffo E; Borin C; Boldrin E; Meyer LH; Te Kronnie G; Bresolin S; Bortoluzzi S
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36585787
[TBL] [Abstract][Full Text] [Related]
2. Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion.
Tretti Parenzan C; Molin AD; Longo G; Gaffo E; Buratin A; Cani A; Boldrin E; Serafin V; Guglielmelli P; Vannucchi AM; Cazzaniga G; Biondi A; Locatelli F; Meyer LH; Buldini B; Te Kronnie G; Bresolin S; Bortoluzzi S
Blood Adv; 2024 Mar; 8(5):1305-1319. PubMed ID: 38029383
[TBL] [Abstract][Full Text] [Related]
3. circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression.
Huang W; Fang K; Chen TQ; Zeng ZC; Sun YM; Han C; Sun LY; Chen ZH; Yang QQ; Pan Q; Luo XQ; Wang WT; Chen YQ
J Hematol Oncol; 2019 Oct; 12(1):103. PubMed ID: 31623653
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
[TBL] [Abstract][Full Text] [Related]
5. CircRNAs Are Here to Stay: A Perspective on the
Dal Molin A; Bresolin S; Gaffo E; Tretti C; Boldrin E; Meyer LH; Guglielmelli P; Vannucchi AM; Te Kronnie G; Bortoluzzi S
Front Genet; 2019; 10():88. PubMed ID: 30815012
[TBL] [Abstract][Full Text] [Related]
6. Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia.
Conn VM; Gabryelska M; Toubia J; Kirk K; Gantley L; Powell JA; Cildir G; Marri S; Liu R; Stringer BW; Townley S; Webb ST; Lin H; Samaraweera SE; Bailey S; Moore AS; Maybury M; Liu D; Colella AD; Chataway T; Wallington-Gates CT; Walters L; Sibbons J; Selth LA; Tergaonkar V; D'Andrea RJ; Pitson SM; Goodall GJ; Conn SJ
Cancer Cell; 2023 Jul; 41(7):1309-1326.e10. PubMed ID: 37295428
[TBL] [Abstract][Full Text] [Related]
7. Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.
Pincez T; Landry JR; Roussy M; Jouan L; Bilodeau M; Laramée L; Couture F; Sinnett D; Gendron P; Hébert J; Oligny L; Rouette A; Tran TH; Wilhelm BT; Bittencourt H; Cellot S
Genes Chromosomes Cancer; 2020 Feb; 59(2):125-130. PubMed ID: 31515871
[TBL] [Abstract][Full Text] [Related]
8. The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features.
Ragusa D; Makarov EM; Britten O; Moralli D; Green CM; Tosi S
Cancer Rep (Hoboken); 2019 Oct; 2(5):e1207. PubMed ID: 32721124
[TBL] [Abstract][Full Text] [Related]
9. A new variant of KMT2A(MLL)-FLNA fusion transcript in acute myeloid leukemia with ins(X;11)(q28;q23q23).
Matveeva E; Kazakova A; Olshanskaya Y; Tsaur G; Shelikhova L; Meyer C; Marschalek R; Novichkova G; Maschan M; Maschan A
Cancer Genet; 2015 Apr; 208(4):148-51. PubMed ID: 25892123
[TBL] [Abstract][Full Text] [Related]
10. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
[TBL] [Abstract][Full Text] [Related]
11. HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia.
Wu Z; Eguchi-Ishimae M; Yagi C; Iwabuki H; Gao W; Tauchi H; Inukai T; Sugita K; Ishii E; Eguchi M
Br J Haematol; 2015 Dec; 171(5):818-29. PubMed ID: 26403224
[TBL] [Abstract][Full Text] [Related]
12. Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.
Cerveira N; Lisboa S; Correia C; Bizarro S; Santos J; Torres L; Vieira J; Barros-Silva JD; Pereira D; Moreira C; Meyer C; Oliva T; Moreira I; Martins Â; Viterbo L; Costa V; Marschalek R; Pinto A; Mariz JM; Teixeira MR
Mol Oncol; 2012 Oct; 6(5):553-64. PubMed ID: 22846743
[TBL] [Abstract][Full Text] [Related]
13. [Biological microchip for establishing the structure of fusion transcripts involving MLL in children with acute leukemia].
Nasedkina TV; Ikonnikova AY; Tsaur GA; Karateeva AV; Ammour YI; Avdonina MA; Karachunskii AI; Zasedatelev AS
Mol Biol (Mosk); 2016; 50(6):968-977. PubMed ID: 28064313
[TBL] [Abstract][Full Text] [Related]
14. Fcirc: A comprehensive pipeline for the exploration of fusion linear and circular RNAs.
Cai Z; Xue H; Xu Y; Köhler J; Cheng X; Dai Y; Zheng J; Wang H
Gigascience; 2020 Jun; 9(6):. PubMed ID: 32470133
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia.
Bizarro S; Cerveira N; Correia C; Lisboa S; Peixoto A; Norton L; Teixeira MR
Cancer Genet Cytogenet; 2007 Oct; 178(1):61-4. PubMed ID: 17889710
[TBL] [Abstract][Full Text] [Related]
16. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
[TBL] [Abstract][Full Text] [Related]
17. Genome editing-induced t(4;11) chromosomal translocations model B cell precursor acute lymphoblastic leukemias with KMT2A-AFF1 fusion.
Pan F; Sarno J; Jeong J; Yang X; Jager A; Gruber TA; Davis KL; Cleary ML
J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 37917159
[TBL] [Abstract][Full Text] [Related]
18. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
[TBL] [Abstract][Full Text] [Related]
19. Therapy-induced Deletion in 11q23 Leading to Fusion of
Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
Zerkalenkova E; Lebedeva S; Kazakova A; Tsaur G; Starichkova Y; Timofeeva N; Soldatkina O; Aprelova E; Popov A; Ponomareva N; Baidun L; Meyer C; Novichkova G; Maschan M; Maschan A; Marschalek R; Olshanskaya Y
Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
